Synthesis of active site-directed organometallic irreversible protease inhibitors.
p-Antimonybenzenesulfonyl fluoride and p-mercurybenzenesulfonyl fluoride irreversibly inhibit chymotrypsin (EC 3.4.21.1), trypsin (EC 3.4.21.4), and chromosomal protease, and these inhibitors appear to be as active as phenylmethanesulfonyl fluoride. The pretreatment of the proteases interferes with the phosphorylation of the active-site serine by diisopropylfluorophosphate suggesting that the organometallic inhibitors may also interact with the active site serine. The organometallic inhibitors may be used for localization of proteases in different parts of the cell by electron microscopy and p-mercurybenzenesulfonyl fluoride could also be used for isolation of proteases by sulfhydryl affinity chromatography.
D000818:Animals; D001557:Benzenesulfonates; D002467:Cell Nucleus / Q000201:enzymology; D002875:Chromosomes / Q000201:enzymology; D002918:Chymotrypsin / Q000037:antagonists & inhibitors*; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D009941:Organomercury Compounds; D009942:Organometallic Compounds; D011480:Protease Inhibitors / Q000494:pharmacology*; D051381:Rats; D014361:Trypsin Inhibitors / Q000494:pharmacology*
C019260:4-antimonybenzenesulfonyl fluoride; C028265:4-mercurybenzenesulfonyl fluoride; D001557:Benzenesulfonates; D009941:Organomercury Compounds; D009942:Organometallic Compounds; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D002918:Chymotrypsin